234 related articles for article (PubMed ID: 22014025)
1. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
[TBL] [Abstract][Full Text] [Related]
2. CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects.
Ji YN; Wang Q; Lin XQ; Suo LJ
Cytokine; 2012 Aug; 59(2):324-34. PubMed ID: 22579698
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1 exon7 polymorphism is associated with lung cancer risk among the female population and among smokers: a meta-analysis.
Xu CH; Wang Q; Qian Q; Zhan P; Yu LK
Tumour Biol; 2013 Dec; 34(6):3901-11. PubMed ID: 23832578
[TBL] [Abstract][Full Text] [Related]
4. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.
Chen Z; Li Z; Niu X; Ye X; Yu Y; Lu S; Chen Z
Mutagenesis; 2011 May; 26(3):437-46. PubMed ID: 21402622
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis.
Ji YN; Wang Q; Suo LJ
PLoS One; 2012; 7(8):e43397. PubMed ID: 22952673
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis.
Li W; Song LQ; Tan J
Tumour Biol; 2014 Sep; 35(9):9281-90. PubMed ID: 24938875
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.
Liu C; Jiang Z; Deng QX; Zhao YN
Asian Pac J Cancer Prev; 2014; 15(11):4689-95. PubMed ID: 24969905
[TBL] [Abstract][Full Text] [Related]
8. MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis.
Wu B; Liu K; Huang H; Yuan J; Yuan W; Wang S; Chen T; Zhao H; Yin C
PLoS One; 2013; 8(12):e85166. PubMed ID: 24391993
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
[TBL] [Abstract][Full Text] [Related]
10. Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies.
Yu L; Sun L; Jiang YF; Lu BL; Sun DR; Zhu LY
Mol Biol Rep; 2012 Jun; 39(6):6641-6. PubMed ID: 22297691
[TBL] [Abstract][Full Text] [Related]
11. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.
Hung RJ; Boffetta P; Brockmöller J; Butkiewicz D; Cascorbi I; Clapper ML; Garte S; Haugen A; Hirvonen A; Anttila S; Kalina I; Le Marchand L; London SJ; Rannug A; Romkes M; Salagovic J; Schoket B; Gaspari L; Taioli E
Carcinogenesis; 2003 May; 24(5):875-82. PubMed ID: 12771031
[TBL] [Abstract][Full Text] [Related]
12. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis.
Fan W; Huang Z; Xiao Z; Li S; Ma Q
J Assist Reprod Genet; 2016 Oct; 33(10):1373-1383. PubMed ID: 27525656
[TBL] [Abstract][Full Text] [Related]
13. CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis.
Shi X; Zhou S; Wang Z; Zhou Z; Wang Z
Lung Cancer; 2008 Feb; 59(2):155-63. PubMed ID: 17900751
[TBL] [Abstract][Full Text] [Related]
14. [Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis].
Dai LP; Wang YP; Wu XB; Wang KJ; Lv QJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1198-202. PubMed ID: 20193595
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Taiwan.
Wu MT; Lee JM; Wu DC; Ho CK; Wang YT; Lee YC; Hsu HK; Kao EL
Br J Cancer; 2002 Aug; 87(5):529-32. PubMed ID: 12189551
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes in the population of Inner Mongolia region.
Jiang XY; Chang FH; Bai TY; Lv XL; Wang MJ
Asian Pac J Cancer Prev; 2014; 15(13):5207-14. PubMed ID: 25040976
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility.
Xu X; Kelsey KT; Wiencke JK; Wain JC; Christiani DC
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):687-92. PubMed ID: 8877059
[TBL] [Abstract][Full Text] [Related]
18. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis.
Zheng Y; Wang JJ; Sun L; Li HL
Mol Biol Rep; 2012 Apr; 39(4):3533-40. PubMed ID: 21710246
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk.
Guo R; Guo X
Tumour Biol; 2012 Aug; 33(4):1125-32. PubMed ID: 22359202
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.
Gong FF; Lu SS; Hu CY; Qian ZZ; Feng F; Wu YL; Yang HY; Sun YH
Tumour Biol; 2014 Oct; 35(10):10351-61. PubMed ID: 25048966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
